ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Lupus

Lupus

Anca D. Askanase, M.D., MPH

LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.

Richard Alan Furie, M.D.

Anifrolumab, a type 1 interferon receptor antagonist, performs well in early trial, researchers show.

Childhood to adult (©NStudio/Shutterstock.com)

A longitudinal study of adults with childhood-onset lupus shows that disease damage accrues over the entire disease course.

(Systemic Lupus Erythematosus  ©farland80/Shutterstock.com)

For systemic lupus erythematosus patients prescribed glucocorticosteroids, mortality has been found to be more frequent than in patients not prescribed glucocorticosteroids, researchers say.

(©CherylCasey/Shutterstock.com)

There are few tests to accurately assess the degree and effects of lupus in children, but Ped-ANAM proves to be a promising option.

Lupus (©Designer491/Shutterstock.com)

Lupus patients who receive healthcare at more than one location face a greater risk of infection and comorbidities, research shows.

(Blisters ©komkritPreechachanwat/Shutterstock.com)

Researchers have made an important discovery that may lead to new treatment for patients with bullous pemphigoid, a chronic autoimmune skin disease causing blisters.

Pages

Subscribe to Lupus on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.